# Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy

> **NCT03920033** · NA · RECRUITING · sponsor: **Asan Medical Center** · enrollment: 288 (estimated)

## Conditions studied

- Prostate Cancer
- Biochemical Recurrence
- Radiation
- Hypofractionation
- Dose Escalation
- Survival
- Radiation Toxicity
- Quality of Life

## Interventions

- **RADIATION:** Salvage radiation therapy

## Key facts

- **NCT ID:** NCT03920033
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920033, "Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03920033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*